
Creoptix AG closes CHF8m financing round
The financing round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation as well as existing private investors....

bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

EU with poor success in fighting superbugs
Although some progress has been made through EU action, there is little evidence so far to suggest that the health burden of antimicrobial resistance...

Gut bacterial enzyme keeps inflammation away
In studies in human cells, Victor Duarte and colleagues from University of Grenoble, found broad-spectrum antimicrobial activity of a compound...

Boehringer and Zealand to advance obesity drug
Boehringer is collaborating with Danish Zealand Pharma on a long-acting amylin analogue (BI 473494) and a GLP-1/glucagon dual-acting agonist (BI...

ADC Therapeutics set to go public
The number of shares to be offered and the price range for the proposed offering have still to be determined. Despite an internal review conducted...

DPP3 triggers myocardial depression
Results of two independent studies published fast-track and presented on Saturday at ESC Congress 2019 (Paris) by Prof. Alexandre Mebazza...